Schedule 13G ownership disclosure
Sionna Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 829401108
Event date: 2025-06-30
- Filing-level shares
- 2,221,188.0
- Percent of class
- 5.0%
- JPMORGAN CHASE & CO.
Shares: 2,221,188.0 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000580
- Form type
- SCHEDULE 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Jul 30, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership